H1N1 RNA DETECTION^

H1N1 RNA DETECTION^ is a molecular test that identifies the genetic material (RNA) of the Influenza A (H1N1) virus using real‑time reverse transcription PCR (RT‑PCR). By detecting viral RNA from a respiratory swab, the test provides a sensitive and specific result that confirms active infection and helps distinguish H1N1 from other respiratory pathogens.

The test is indicated for patients with influenza‑like illness, severe respiratory symptoms, recent exposure to confirmed cases, and high‑risk groups such as pregnant women, young children, older adults, and individuals with chronic illnesses. Home sample collection by trained personnel combined with processing in UAE‑certified laboratories ensures fast turnaround times to support timely antiviral therapy, isolation decisions, and public‑health management.

• Influenza A (H1N1) viral RNA — Qualitative result
• Cycle threshold (Ct) value — If reported
• Specimen type — Nasopharyngeal / Throat swab

• Onset of fever with cough or sore throat (influenza‑like illness)
• Rapidly worsening respiratory symptoms or shortness of breath
• Recent close contact with a confirmed H1N1 case
• Members of high‑risk groups presenting with symptoms
• During suspected local outbreaks or for travel‑related screening

• High sensitivity and specificity for active H1N1 infection
• Convenient home sample collection by trained staff
• Processing in UAE‑certified laboratories for reliable results
• Fast results to guide prompt antiviral treatment and isolation
• Reduces unnecessary hospital visits and supports public‑health response

• At‑home nasopharyngeal or throat swab collection by trained professional
• No fasting required; remain available for the scheduled collection
• Inform provider of any recent antiviral use or sample collection >7 days after symptom onset
• Valid ID and consent for testing and laboratory processing in the UAE